Literature DB >> 12052704

Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin.

Shinji Sakuma1, Norio Suzuki, Rika Sudo, Ken-ichiro Hiwatari, Akio Kishida, Mitsuru Akashi.   

Abstract

Nanoparticles having two kinds of surface hydrophilic polymeric chains were prepared by the free radical copolymerization between styrene and hydrophilic macromonomers terminating in vinylbenzyl groups. Their potential as carriers for oral peptide delivery was investigated using salmon calcitonin (sCT) in rats. After oral administration of mixtures of sCT and nanoparticles, the ionized calcium concentration in blood was measured. The absorption of sCT was significantly enhanced by nanoparticles having poly-N-isopropylacrylamide (PNIPAAm) chains on their surfaces. This enhancement effect was considerably increased by introducing cationic poly-vinylamine (PVAm) groups to the surface of PNIPAAm nanoparticles. The absorption enhancement depended on the ratio of NIPAAm and VAm macromonomers to styrene in the nanoparticle preparation. In contrast, the introduction of nonionic poly-vinylacetamide (PNVA) groups eliminated completely the absorption-enhancing function of PNIPAAm nanoparticles. It was suggested that this disappearance was due to the shielding of PNIPAAm groups by PNVA groups. The enhancement effect of sCT absorption by nanoparticles was greatly dominated by their chemical structure that was closely related to surface characteristics. Optimization of the chemical structure on the basis of the mechanism of the absorption enhancement resulted in the further improvement of sCT absorption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052704     DOI: 10.1016/s0378-5173(02)00113-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Influence of food intake on the bioavailability and efficacy of oral calcitonin.

Authors:  Morten A Karsdal; Inger Byrjalsen; Möise Azria; Michel Arnold; Les Choi; Bente J Riis; Claus Christiansen
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

Review 2.  Lessons learned from the clinical development of oral peptides.

Authors:  Morten Asser Karsdal; Bente Juul Riis; Nozer Mehta; William Stern; Ehud Arbit; Claus Christiansen; Kim Henriksen
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

3.  A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy.

Authors:  Shinji Sakuma; Makoto Kataoka; Haruki Higashino; Takanori Yano; Yoshie Masaoka; Shinji Yamashita; Ken-Ichiro Hiwatari; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Hironori Kumagai; John C Gore; Wellington Pham
Journal:  Eur J Pharm Sci       Date:  2011-01-07       Impact factor: 4.384

Review 4.  Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.

Authors:  Ashaben Patel; Mitesh Patel; Xiaoyan Yang; Ashim K Mitra
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

5.  Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.

Authors:  Morten A Karsdal; Inger Byrjalsen; Bente J Riis; Claus Christiansen
Journal:  BMC Clin Pharmacol       Date:  2008-09-09

6.  Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin.

Authors:  M A Karsdal; I Byrjalsen; B J Riis; C Christiansen
Journal:  BMC Clin Pharmacol       Date:  2008-12-04

7.  Preparation of Nanoparticles Including Antisolvent Drugs by the 
Combination of Roll Milling and High-pressure Homogenization.

Authors:  Seitaro Kamiya; Maya Yamada; Miki Washino; Kenichiro Nakashima
Journal:  Curr Nanosci       Date:  2018-04       Impact factor: 1.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.